相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Multi-tissue, selective PPAR gamma modulation of insulin sensitivity and metabolic pathways in obese rats
Gene Hsiao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Prioritizing candidate disease genes by network-based boosting of genome-wide association data
Insuk Lee et al.
GENOME RESEARCH (2011)
Rosiglitazone-Induced Mitochondrial Biogenesis in White Adipose Tissue Is Independent of Peroxisome Proliferator-Activated Receptor γ Coactivator-1α
Rosario Pardo et al.
PLOS ONE (2011)
Diabetes mellitus complicating systemic lupus erythematosus - analysis of the UCL lupus cohort and review of the literature
S. Cortes et al.
LUPUS (2008)
Effect of vanadate on gene expression of the insulin signaling pathway in skeletal muscle of streptozotocin-induced diabetic rats
Dan Wei et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2007)
Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone
James X. Rong et al.
DIABETES (2007)
Cardiovascular safety of rosiglitazone
Ronald L. Krall
LANCET (2007)
Obesity, inflammation, and insulin resistance
Steven E. Shoelson et al.
GASTROENTEROLOGY (2007)
Inflammation and insulin resistance
Steven E. Shoelson et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Global gene expression analysis in liver of obese diabetic db/db mice treated with metformin
M. Heishi et al.
DIABETOLOGIA (2006)
Microarray profiling of gene expression in human adipocytes in response to anthocyanins
T Tsuda et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Blood glucose-lowering nuclear receptor agonists only partially normalize hepatic gene expression in db/db mice
M Loffler et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Chronic rosiglitazone treatment restores AMPKα2 activity in insulin-resistant rat skeletal muscle
SJ Lessard et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Efficacy of glimepiride on insulin resistance, adipocytokines, and atherosclerosis
Kunihiko Koshiba et al.
JOURNAL OF MEDICAL INVESTIGATION (2006)
Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus
BK Irons et al.
PHARMACOTHERAPY (2006)
Effect of rosiglitazone and nateglinide on serum glucose and lipid profile alone or in combination with the biguanide metformin in diabetic rats
SA El-Batran et al.
PHARMACOLOGICAL RESEARCH (2006)
Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones
CJ Bailey
DIABETES OBESITY & METABOLISM (2005)
A peroxisome proliferator-activated receptor α/γ dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia
A Reifel-Miller et al.
MOLECULAR ENDOCRINOLOGY (2005)
Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo
I Bogacka et al.
DIABETES (2005)
Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes
M Tiikkainen et al.
DIABETES (2004)
Effect of rosiglitazone on the differential expression of obesity and insulin resistance associated proteins in lep/lep mice
JC Sanchez et al.
PROTEOMICS (2003)
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes:: Potential role of PGC1 and NRF1
ME Patti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
VK Mootha et al.
NATURE GENETICS (2003)
Monocyte chemoattractant protein 1 in obesity and insulin resistance
P Sartipy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Metformin hydrochloride in the treatment of type 2 diabetes mellitus: A clinical review with a focus on dual therapy
SM Setter et al.
CLINICAL THERAPEUTICS (2003)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Linear models for microarray data analysis: Hidden similarities and differences
MK Kerr
JOURNAL OF COMPUTATIONAL BIOLOGY (2003)
The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism
SA Hawley et al.
DIABETES (2002)
The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways
LGD Fryer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes
N Musi et al.
DIABETES (2002)
Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment
R Sreekumar et al.
DIABETES (2002)
Cardiac troponin T is essential in sarcomere assembly and cardiac contractility
AJ Sehnert et al.
NATURE GENETICS (2002)
Insulin signalling and the regulation of glucose and lipid metabolism
AR Saltiel et al.
NATURE (2001)
Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats
D Kramer et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2001)
Globalization, coca-colonization and the chronic disease epidemic: can the Doomsday scenario be averted?
P Zimmet
JOURNAL OF INTERNAL MEDICINE (2000)